(Q33394464)
Statements
1 reference
Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes (English)
1 reference
Jeffrey Palmer
1 reference
Alasdair J Coles
1 reference
Edward Fox
1 reference
Anton Vladic
1 reference
Suzanne K Gazda
1 reference
Vesna Brinar
1 reference
Ann Doan-Do Bass
1 reference
Daniel R Wynn
1 reference
David H Margolin
1 reference
Stephen L Lake
1 reference
Susan Moran
1 reference
M Shelton Smith
1 reference
D Alastair S Compston
1 reference
1 reference
Identifiers
1 reference